Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 08, 2019

SELL
$55.63 - $73.24 $1,335 - $1,757
-24 Closed
0 $0
Q3 2018

Nov 02, 2018

BUY
$52.05 - $66.51 $1,249 - $1,596
24 New
24 $2,000
Q2 2018

Aug 13, 2018

SELL
$48.33 - $55.64 $122,806 - $141,381
-2,541 Closed
0 $0
Q1 2018

May 10, 2018

BUY
$44.44 - $54.39 $112,922 - $138,204
2,541 New
2,541 $134,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $443M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Stratos Wealth Partners, Ltd. Portfolio

Follow Stratos Wealth Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.